Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors

被引:23
作者
Saayman, Sheena [1 ]
Arbuthnot, Patrick [1 ]
Weinberg, Marc S. [1 ]
机构
[1] Univ Witwatersrand, Antiviral Gene Therapy Res Unit, Dept Mol Med & Haematol, Johannesburg, South Africa
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; IN-VITRO; MAMMALIAN-CELLS; LENTIVIRAL VECTORS; MULTIPLE SIRNAS; EXPRESSION; INTERFERENCE; REPLICATION; SHRNA; INHIBITION;
D O I
10.1093/nar/gkq460
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several different approaches exist to generate expressed RNA interference (RNAi) precursors for multiple target inhibition, a strategy referred to as combinatorial (co)RNAi. One such approach makes use of RNA Pol III-expressed long hairpin RNAs (lhRNAs), which are processed by Dicer to generate multiple unique short interfering siRNA effectors. However, because of inefficient intracellular Dicer processing, lhRNA duplexes have been limited to generating two independent effective siRNA species. In this study, we describe a novel strategy whereby four separate anti-HIV siRNAs were generated from a single RNA Pol III-expressed transcript. Two optimized lhRNAs, each comprising two active anti-HIV siRNAs, were placed in tandem to form a double long hairpin (dlhRNA) expression cassette, which encodes four unique and effective siRNA sequences. Processing of the 3' position lhRNA was more variable but effective multiple processing was possible by manipulating the order of the siRNA-encoding sequences. Importantly, unlike shRNAs, Pol III-expressed dlhRNAs did not compete with endogenous and exogenous microRNAs to disrupt the RNAi pathway. The versatility of expressed lhRNAs is greatly expanded and we provide a mechanism for generating transcripts with modular lhRNAs motifs that contribute to improved coRNAi.
引用
收藏
页码:6652 / 6663
页数:12
相关论文
共 53 条
[1]   Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs [J].
Aagaard L.A. ;
Zhang J. ;
von Eije K.J. ;
Li H. ;
Sætrom P. ;
Amarzguioui M. ;
Rossi J.J. .
Gene Therapy, 2008, 15 (23) :1536-1549
[2]   Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA [J].
Akashi, H ;
Miyagishi, M ;
Yokota, T ;
Watanabe, T ;
Hino, T ;
Nishina, K ;
Kohara, M ;
Taira, K .
MOLECULAR BIOSYSTEMS, 2005, 1 (5-6) :382-390
[3]   Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors [J].
An, Dong Sung ;
Qin, F. Xiao-Feng ;
Auyeung, Vincent C. ;
Mao, Si Hua ;
Kung, Sam K. P. ;
Baltimore, David ;
Chen, Irvin S. Y. .
MOLECULAR THERAPY, 2006, 14 (04) :494-504
[4]   Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells [J].
An, WF ;
Telesnitsky, A .
VIROLOGY, 2001, 286 (02) :475-482
[5]   Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance [J].
Anderson, J ;
Banerjea, A ;
Akkina, R .
OLIGONUCLEOTIDES, 2003, 13 (05) :303-312
[6]   The inhibitory efficacy of RNA POL III-Expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5′ long terminal repeat [J].
Barichievy, Samantha ;
Saayman, Sheena ;
Von Eije, Karin J. ;
Morris, Kevin V. ;
Arbuthnot, Patrick ;
Weinberg, Marc S. .
OLIGONUCLEOTIDES, 2007, 17 (04) :419-431
[7]  
Bertrand E, 1997, RNA, V3, P75
[8]   Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo [J].
Boudreau, Ryan L. ;
Martins, Ines ;
Davidson, Beverly L. .
MOLECULAR THERAPY, 2009, 17 (01) :169-175
[9]   Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs [J].
Carmona, S ;
Ely, A ;
Crowther, C ;
Moolla, N ;
Salazar, FH ;
Marion, PL ;
Ferry, N ;
Weinberg, MS ;
Arbuthnot, P .
MOLECULAR THERAPY, 2006, 13 (02) :411-421
[10]   Functional siRNA expression from transfected PCR products [J].
Castanotto, D ;
Li, HT ;
Rossi, JJ .
RNA, 2002, 8 (11) :1454-1460